We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

IDO Pathway Products for Immunotherapy Drug Research

Product News   May 16, 2017 | Original story from AMSBIO

 
IDO Pathway Products for Immunotherapy Drug Research

Credit: AMSBIO

FURTHER INFORMATION
 
 
 

Related Product News

Adaptate Biotherapeutics Formed To Develop T-cell Modulating Antibody-based Therapies

Product News

A new company aims to modulate γd T-cell activity using therapeutic antibodies, with the potential to trigger an immune response against cancer.

READ MORE

Tumor Regression with New Antibody-Drug Conjugate

Product News

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), has announced the first data on its lead ADC, IKS01.

READ MORE

Product and Personnel Protection With New Biological Safety Cabinet

Product News

Thermo Fisher Scientific has announced the Class II biological safety cabinet (BSC).

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE